Physician profile
Rene Celis
NPI 1902072044
$15,522.96
in general payments reported to CMS, 2019-2025
56 companies · $2,727 in 2025
The $2,727 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,460 · 2020: $1,235 · 2021: $1,541 · 2022: $2,114 · 2023: $2,221 · 2024: $3,226 · 2025: $2,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,290 · Travel and Lodging: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,289.98 |
| Travel and Lodging | $883.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,283.79 | 2021-2025 | Corevalve Evolut R, Hawkone, Venaseal |
| Abbott Laboratories | $1,444.17 | 2020-2024 | Aveir, Amplatzer Amulet, Amplatzer Talisman |
| Aop Health US, LLC | $1,154.90 | 2025 | Rapiblyk |
| Abiomed | $1,038.39 | 2019-2024 | Impella |
| Cvrx, INC. | $724.38 | 2022-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $682.34 | 2019-2024 | Xarelto |
| Amgen INC. | $656.52 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $634.00 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $554.09 | 2019-2025 | Varithena Administration Pack, Watchman Flx |
| Merck Sharp & Dohme LLC | $502.48 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $441.79 | 2019-2025 | |
| Medtronic Vascular, INC. | $423.03 | 2019-2020 | |
| Pfizer INC. | $422.00 | 2019-2025 | |
| Cleerly, INC. | $322.66 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Sanofi-Aventis U.S. LLC | $312.82 | 2019-2024 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $306.52 | 2020-2023 | Diamondback Coronary |
| Penumbra, INC. | $275.69 | 2019-2024 | Indigo System |
| Atricure, INC. | $237.51 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Amarin Pharma, INC. | $226.38 | 2019-2021 | |
| Philips North America LLC | $206.96 | 2019-2025 | Ecc Solutions, (Cm9) Amb Mon & Diag Und, (Bs0) Mechanical Atherectomy |
| Astrazeneca Pharmaceuticals Lp | $206.89 | 2019-2025 | Farxiga |
| W. L. Gore & Associates, INC. | $191.72 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $178.46 | 2019-2025 | Camzyos |
| Stryker Corporation | $173.44 | 2019 | |
| Novo Nordisk INC | $165.00 | 2021-2023 | Ozempic, Wegovy |
| Kestra Medical Technology Services, INC. | $163.45 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.69 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $140.83 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Teleflex LLC | $128.58 | 2020-2025 | Turnpike, Trapliner |
| Inari Medical, INC. | $118.15 | 2022 | |
| United Therapeutics Corporation | $104.16 | 2025 | Tyvaso |
| Alnylam Pharmaceuticals INC. | $90.02 | 2022-2025 | Amvuttra |
| Impulse Dynamics (USA) INC. | $83.60 | 2023-2024 | Optimizer, Optimizer |
| Chiesi USA, INC. | $83.10 | 2019-2025 | Cleviprex, Kengreal |
| Kowa Pharmaceuticals America, INC. | $79.98 | 2020-2021 | |
| Esperion Therapeutics, INC. | $70.05 | 2020-2022 | |
| Biotronik INC. | $60.51 | 2019-2020 | |
| Arineta, INC | $60.10 | 2024 | Spotlight |
| Cook Medical LLC | $54.28 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $53.07 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.83 | 2021-2025 | |
| Angiodynamics, INC. | $29.39 | 2024 | Alphavac |
| Edwards Lifesciences Corporation | $28.13 | 2022 | |
| Braemar Manufacturing, LLC | $24.79 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $22.16 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $21.91 | 2024 | Arcalyst |
| Aegerion Pharmaceuticals, INC. | $18.73 | 2019 | |
| Amryt Pharma Holdings Ltd | $17.64 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $17.33 | 2019 | |
| Avinger INC. | $16.00 | 2022 | |
| Bsn Medical INC | $15.68 | 2024 | |
| Gilead Sciences, INC. | $14.91 | 2019 | |
| Bracco Diagnostics INC. | $12.83 | 2019 | |
| Bardy Diagnostics, INC. | $12.50 | 2021 | |
| Zoll Circulation INC | $12.50 | 2022 | |
| Acist Medical Systems, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Celis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.